The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Guidelines of care for the management of primary cutaneous melanoma
Open accessAbstract
The incidence of primary cutaneous melanoma has been increasing dramatically for several decades. Melanoma accounts for the majority of skin cancer-related deaths, but treatment is nearly always curative with early detection of disease. In this update of the guidelines of care, we will discuss the treatment of patients with primary cutaneous melanoma. We will discuss biopsy techniques of a lesion clinically suspicious for melanoma and offer recommendations for the histopathologic interpretation of cutaneous melanoma. We will offer recommendations for the use of laboratory and imaging tests in the initial workup of patients with newly diagnosed melanoma and for follow-up of asymptomatic patients. With regard to treatment of primary cutaneous melanoma, we will provide recommendations for surgical margins and briefly discuss nonsurgical treatments. Finally, we will discuss the value and limitations of sentinel lymph node biopsy and offer recommendations for its use in patients with primary cutaneous melanoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Computed Tomography — An Increasing Source of Radiation Exposure
Brenner, D. J., & Hall, E. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra072149 · Cited by 8,748
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Final Version of 2009 AJCC Melanoma Staging and Classification
Balch, C. M., Gershenwald, J. E., Soong, S.-J., Thompson, J. F., Atkins, M. B., Byrd, D. R., Buzaid, A. C., Cochran, A. J., Coit, D. G., Ding, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.4799 · Cited by 4,602
Self-citationCombined BRAF and MEK inhibition in melanoma with BRAF V600 mutations
Flaherty, K. T., Infante, J. R., Daud, A., Gonzalez, R., Kefford, R. F., Sosman, J., Hamid, O., Schuchter, L., Cebon, J., Ibrahim, N., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1210093 · Cited by 2,810
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, K. T., Robert, C., Hersey, P., Nathan, P., Garbe, C., Milhem, M., Demidov, L. V., Hassel, J. C., Rutkowski, P., Mohr, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203421 · Cited by 2,160
Atkins, M. B., Lotze, M. T., Dutcher, J. P., Fisher, R. I., Weiss, G., Margolin, K., Abrams, J., Sznol, M., Parkinson, D., Hawkins, M., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.7.2105 · Cited by 2,048
Sentinel-Node Biopsy or Nodal Observation in Melanoma
Morton, D. L., Thompson, J. F., Cochran, A. J., Mozzillo, N., Elashoff, R., Essner, R., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., Karakousis, C. P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060992 · Cited by 1,824
American Joint Committee on Cancer (2010) · Springer eBooks · doi:10.1007/978-0-387-88441-7 · Cited by 1,328
Model Predicting Survival in Stage I Melanoma Based on Tumor Progression
Clark, W. H., Elder, D. E., Guerry, D., Braitman, L. E., Trock, B. J., Schultz, D., Synnestvedt, M., & Halpern, A. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.24.1893 · Cited by 1,247
Self-citationClemente, C. G., Mihm, M. C., Bufalino, R., Zurrida, S., Collini, P., & Cascinelli, N. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960401)77:7<1303::aid-cncr12>3.0.co;2-5 · Cited by 1,171
Ross, J. F., Chaudhuri, P. K., & Ratnam, M. (1994) · Cancer · doi:10.1002/1097-0142(19940501)73:9<2324::aid-cncr2820730914>3.0.co;2-5 · Cited by 900
Morton, D. L., Cochran, A. J., Thompson, J. F., Elashoff, R., Essner, R., Glass, E. C., Mozzillo, N., Nieweg, O. E., Roses, D. F., Hoekstra, H. J., et al. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000181092.50141.fa · Cited by 715
Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dummer, R., Hauschild, A., Guggenheim, M., Keilholz, U., & Pentheroudakis, G. (2012) · Annals of Oncology · doi:10.1093/annonc/mds229 · Cited by 714
Garbe, C., Peris, K., Hauschild, A., Saiag, P., Middleton, M., Bastholt, L., Grob, J.-J., Malvehy, J., Newton-Bishop, J., Stratigos, A. J., et al. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.05.005 · Cited by 605
Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth, A., Wanek, L. A., & Morton, D. L. (1995) · PubMed · Cited by 569
Thin Stage I Primary Cutaneous Malignant Melanoma
Veronesi, U., Cascinelli, N., Adamus, J., Balch, C., Bandiera, D., Barchuk, A., Bufalino, R., Craig, P., De Marsillac, J., Durand, J. C., et al. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181804 · Cited by 563
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J., Ewigman, B., & Bowman, M. (2004) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.17.1.59 · Cited by 561
Balch, C. M., Urist, M. M., Karakousis, C. P., Smith, T. J., Temple, W. J., Drzewiecki, K., Jewell, W. R., Bartolucci, A. A., Mihm, M. C., Barnhill, R., et al. (1993) · Annals of Surgery · doi:10.1097/00000658-199309000-00005 · Cited by 525
Excision Margins in High-Risk Malignant Melanoma
Thomas, J. M., Newton‐Bishop, J., A’Hern, R., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa030681 · Cited by 504
Narrow Excision (1-cm Margin): A Safe Procedure for Thin Cutaneous Melanoma
Veronesi, U. (1991) · Archives of Surgery · doi:10.1001/archsurg.1991.01410280036004 · Cited by 495
Gene Expression Profiling of Primary Cutaneous Melanoma and Clinical Outcome
Winnepenninckx, V., Lazar, V., Michiels, S., Dessen, P., Stas, M., Alonso, S. R., Avril, M.-F., Ortiz Romero, P. L., Robert, T., Balacescu, O., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj103 · Cited by 480
Kim, K. B., Kefford, R., Pavlick, A. C., Infante, J. R., Ribas, A., Sosman, J. A., Fecher, L. A., Millward, M., McArthur, G. A., Hwu, P., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.5966 · Cited by 477
Balch, C. M., Soong, S.-J., Smith, T., Ross, M. I., Urist, M. M., Karakousis, C. P., Temple, W. J., Mihm, M. C., Barnhill, R. L., Jewell, W. R., et al. (2001) · Annals of Surgical Oncology · doi:10.1007/s10434-001-0101-x · Cited by 406
Marsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., et al. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.09883.x · Cited by 396
Thompson, J. F., Soong, S.-J., Balch, C. M., Gershenwald, J. E., Ding, S., Coit, D. G., Flaherty, K. T., Gimotty, P. A., Johnson, T., Johnson, M. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.5812 · Cited by 363
Self-citationThe prognostic significance of ulceration of cutaneous melanoma
Balch, C. M., Wilkerson, J. A., Murad, T. M., Soong, S.-J., Ingalls, A. L., & Maddox, W. A. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o · Cited by 361
Xing, Y., Bronstein, Y., Ross, M. I., Askew, R. L., Lee, J. E., Gershenwald, J. E., Royal, R., & Cormier, J. N. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq455 · Cited by 352
Sondak, V. K., Taylor, J. M. G., Sabel, M. S., Wang, Y., Lowe, L., Grover, A. C., Chang, A. E., Yahanda, A. M., Moon, J., & Johnson, T. M. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.03.044 · Cited by 328
Self-citationU.K. guidelines for the management of cutaneous melanoma
Roberts, D. L., Anstey, A. V., Barlow, R., Cox, N. H., Newton‐Bishop, J., Corrie, P. G., Evans, J., Gore, M. E., Hall, P. N., & Kirkham, N. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04614.x · Cited by 324
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
Carbone, M., Ferris, L. K., Baumann, F., Napolitano, A., Lum, C. A., Flores, E. G., Gaudino, G., Powers, A., Bryant-Greenwood, P., Krausz, T., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-179 · Cited by 323
Atkins, M. B., Hsu, J., Lee, S., Cohen, G. I., Flaherty, L. E., Sosman, J. A., Sondak, V. K., & Kirkwood, J. M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.5448 · Cited by 320
Predicting five-year outcome for patients with cutaneous melanoma in a population-based study
Barnhill, R. L., Fine, J. A., Roush, G. C., & Berwick, M. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960801)78:3<427::aid-cncr8>3.0.co;2-g · Cited by 296
Tumours associated with BAP1 mutations
Murali, R., Wiesner, T., & Scolyer, R. A. (2013) · Pathology · doi:10.1097/pat.0b013e32835d0efb · Cited by 270
Romano, E., Scordo, M., Dusza, S. W., Coit, D. G., & Chapman, P. B. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.2063 · Cited by 256
Njauw, C.-N. J., Kim, I., Piris, A., Gabree, M., Taylor, M., Lane, A. M., DeAngelis, M. M., Gragoudas, E., Duncan, L. M., & Tsao, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035295 · Cited by 254
Self-citationKarakousis, C. P., Balch, C. M., Urist, M. M., Ross, M. M., Smith, T. J., & Bartolucci, A. A. (1996) · Annals of Surgical Oncology · doi:10.1007/bf02305762 · Cited by 239
Clinicopathological Features of and Risk Factors for Multiple Primary Melanomas
Ferrone, C. R. (2005) · JAMA · doi:10.1001/jama.294.13.1647 · Cited by 233
Gillgren, P., Drzewiecki, K. T., Niin, M., Gullestad, H. P., Hellborg, H., Månsson-Brahme, E., Ingvar, C., & Ringborg, U. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61546-8 · Cited by 228
Cutaneous head and neck melanoma treated with Mohs micrographic surgery
Bricca, G. M., Brodland, D. G., Ren, D., & Zitelli, J. A. (2005) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.08.038 · Cited by 216
Revised UK guidelines for the management of cutaneous melanoma 2010
Marsden, J. R., Newton-Bishop, J. A., Burrows, L., Cook, M., Corrie, P. G., Cox, N. H., Gore, M. E., Lorigan, P., MacKie, R., Nathan, P., et al. (2010) · Journal of Plastic, Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2010.07.006 · Cited by 215
Guidelines of care for primary cutaneous melanoma
Sober, A. J., Chuang, T.-Y., Duvic, M., Farmer, E. R., Grichnik, J. M., Halpern, A. C., Ho, V., Holloway, V., Hood, A. F., Johnson, T. M., et al. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.117044 · Cited by 215
Self-citationMelanoma MicroRNA Signature Predicts Post-Recurrence Survival
Segura, M. F., Belitskaya-Lévy, I., Rose, A. E., Zakrzewski, J., Gaziel, A., Hanniford, D., Darvishian, F., Berman, R. S., Shapiro, R. L., Pavlick, A. C., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-2721 · Cited by 215
Lymphatic Mapping and Sentinel Lymph Node Biopsy in Patients With Melanoma: A Meta-Analysis
Valsecchi, M. E., Silbermins, D., de Rosa, N., Wong, S. L., & Lyman, G. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.1884 · Cited by 209
Identification of High-Risk Patients Among Those Diagnosed With Thin Cutaneous Melanomas
Gimotty, P. A., Elder, D. E., Fraker, D. L., Botbyl, J., Sellers, K., Elenitsas, R., Ming, M. E., Schuchter, L., Spitz, F. R., Czerniecki, B. J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.1463 · Cited by 208
Selection criteria for genetic assessment of patients with familial melanoma
Leachman, S. A., Carucci, J., Kohlmann, W., Banks, K. C., Asgari, M. M., Bergman, W., Bianchi-Scarrà, G., Brentnall, T., Bressac-de Paillerets, B., Bruno, W., et al. (2009) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2009.03.016 · Cited by 198
Self-citationFrancken, A. B., Shaw, H. M., Thompson, J. F., Soong, S.-J., Accortt, N. A., Azzola, M. F., Scolyer, R. A., Milton, G. W., McCarthy, W. H., Colman, M. H., et al. (2004) · Annals of Surgical Oncology · doi:10.1245/aso.2004.07.014 · Cited by 196
ARMSTRONG, B. K. (1984) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072002 · Cited by 194
Wong, S. L., Kattan, M. W., McMasters, K. M., & Coit, D. G. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.05.016 · Cited by 193
Histology of sun-damaged human skin
Montagna, W., Kirchner, S., & Carlisle, K. (1989) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(89)70276-0 · Cited by 192
Malignant melanoma in pregnancy: A population‐based evaluation
O'Meara, A. T., Cress, R., Xing, G., Danielsen, B., & Smith, L. H. (2005) · Cancer · doi:10.1002/cncr.20925 · Cited by 189
Rajpara, S. M., Botello, A. P., Townend, J., & Ormerod, A. D. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2009.09093.x · Cited by 185
Effect of Pregnancy on Survival in Women With Cutaneous Malignant Melanoma
Lens, M. B., Rosdahl, I., Ahlbom, A., Farahmand, B. Y., Synnerstad, I., Boeryd, B., & Newton Bishop, J. A. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.02.096 · Cited by 180
Treatment of lentigo maligna with topical imiquimod
Naylor, M. F., Crowson, N., Kuwahara, R., Teague, K., Garcia, C., Mackinnis, C., Haque, R., Odom, C., Jankey, C., & Cornelison, R. L. (2003) · British Journal of Dermatology · doi:10.1046/j.0366-077x.2003.05637.x · Cited by 167
Ultraviolet A and Photosensitivity during Vemurafenib Therapy
Dummer, R., Rinderknecht, J., & Goldinger, S. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmc1113752 · Cited by 166
Guerry, D., Synnestvedt, M., Elder, D. E., & Schultz, D. (1993) · Journal of Investigative Dermatology · doi:10.1038/jid.1993.60 · Cited by 165
Hofmann, U., Szedlak, M., Rittgen, W., Jung, E. G., & Schadendorf, D. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600428 · Cited by 159
Ng, J. C., Swain, S., Dowling, J. P., Wolfe, R., Simpson, P., & Kelly, J. W. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.14 · Cited by 158
Role of PET in the Initial Staging of Cutaneous Malignant Melanoma: Systematic Review
Krug, B., Crott, R., Lonneux, M., Baurain, J., Pirson, A., & Borght, T. V. (2008) · Radiology · doi:10.1148/radiol.2493080240 · Cited by 149
Desmoplastic Melanoma: A Pathologically and Clinically Distinct Form of Cutaneous Melanoma
Hawkins, W. G., BUSAM, K. J., Ben‐Porat, L., Panageas, K. S., Coit, D. G., Gyorki, D. E., Linehan, D. C., & Brady, M. S. (2005) · Annals of Surgical Oncology · doi:10.1245/aso.2005.03.022 · Cited by 147
Nagore, E., Oliver, V., Estrada, R. B., Moreno-Picot, S., Insa, A., & Fortea, J. M. (2005) · Melanoma Research · doi:10.1097/00008390-200506000-00005 · Cited by 143
Goggins, W. B., & Tsao, H. (2003) · Cancer · doi:10.1002/cncr.11116 · Cited by 140
Self-citationStaged excision versus Mohs micrographic surgery for lentigo maligna and lentigo maligna melanoma
Walling, H. W., Scupham, R. K., Bean, A. K., & Ceilley, R. I. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.02.011 · Cited by 140
Importance of Sentinel Lymph Node Biopsy in Patients With Thin Melanoma
Wright, B. E. (2008) · Archives of Surgery · doi:10.1001/archsurg.143.9.892 · Cited by 132
Leiter, U., Buettner, P. G., Eigentler, T., & Garbe, C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.03.074 · Cited by 127
Coit, D. G., Andtbacka, R. H. I., Bichakjian, C. K., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0020 · Cited by 126
Self-citationHormonal and reproductive factors in relation to melanoma in women: Current review and meta-analysis
Gandini, S., Iodice, S., Koomen, E. R., di Pietro, A., Sera, F., & Caini, S. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.023 · Cited by 125
The Prognostic Importance of Sentinel Lymph Node Biopsy in Thin Melanoma
Ranieri, J. M., Wagner, J. D., Wenck, S., Johnson, C. S., & Coleman, J. J. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.04.023 · Cited by 121
Melanoma In Situ Versus Melanocytic Hyperplasia in Sun-damaged Skin
Weyers, W., Bonczkowitz, M., Weyers, I., Bittinger, A., & Schill, W. (1996) · American Journal of Dermatopathology · doi:10.1097/00000372-199612000-00002 · Cited by 121
Does biopsy type influence survival in clinical Stage I cutaneous melanoma?
Lederman, J. S., & Sober, A. J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)70249-6 · Cited by 119
Self-citationAge-Related Lymphatic Dysfunction in Melanoma Patients
Conway, W. C., Faries, M. B., Nicholl, M. B., Terando, A. M., Glass, E. C., Sim, M., & Morton, D. L. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0420-x · Cited by 117
The importance of mitotic rate as a prognostic factor for localized cutaneous melanoma
Barnhill, R. L., Katzen, J., Spatz, A., Fine, J., & Berwick, M. (2005) · Journal of Cutaneous Pathology · doi:10.1111/j.0303-6987.2005.00310.x · Cited by 117
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma
Kruper, L. L., Spitz, F. R., Czerniecki, B. J., Fraker, D. L., Blackwood‐Chirchir, A., Ming, M. E., Elder, D. E., Elenitsas, R., Guerry, D., & Gimotty, P. A. (2006) · Cancer · doi:10.1002/cncr.22295 · Cited by 115
The prognostic value of serum S100B in patients with cutaneous melanoma: A meta‐analysis
D, S. M. M., Zavagno, G., & Nitti, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23794 · Cited by 114
Berwick, M., Orlow, I., Hummer, A., Armstrong, B. K., Kricker, A., Marrett, L. D., Millikan, R. C., Gruber, S. B., Anton‐Culver, H., Zanetti, R., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0270 · Cited by 114
Gannon, C. J., Rousseau, D. L., Ross, M. I., Johnson, M. M., Lee, J. E., Mansfield, P. F., Cormier, J. N., Prieto, V. G., & Gershenwald, J. E. (2006) · Cancer · doi:10.1002/cncr.22320 · Cited by 111
Efficacy of Skin Self-Examination Practices for Early Melanoma Detection
Pollitt, R. A., Geller, A. C., Brooks, D. R., Johnson, T. M., Park, E. R., & Swetter, S. M. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0310 · Cited by 103
Self-citationBiopsy of the pigmented lesion—When and how
Tran, K. T., Wright, N. A., & Cockerell, C. J. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.05.027 · Cited by 102
Lees, V. C., & Briggs, J. C. (1991) · British journal of surgery · doi:10.1002/bjs.1800780923 · Cited by 97
Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck
Austin, J. R., Byers, R. M., Brown, W. D., & Wolf, P. (1996) · Head & Neck · doi:10.1002/(sici)1097-0347(199603/04)18:2 · Cited by 93
Melanoma underreporting: Why does it happen, how big is the problem, and how do we fix it?
Cockburn, M., Swetter, S. M., Peng, D., Keegan, T. H. M., Deapen, D., & Clarke, C. A. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.08.007 · Cited by 91
Self-citationBreslow thickness and Clark level in melanoma
Marghoob, A. A., Koenig, K., Bittencourt, F. V., Kopf, A. W., & Bart, R. S. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<589::aid-cncr15>3.0.co;2-i · Cited by 88
A nine-gene signature predicting clinical outcome in cutaneous melanoma
Brunner, G., Reitz, M., Heinecke, A., Lippold, A., Berking, C., Suter, L., & Atzpodien, J. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1322-z · Cited by 86
Pregnancy History and Incidence of Melanoma in Women: A Pooled Analysis
Karagas, M. R., Zens, M. S., Stukel, T. A., Swerdlow, A. J., Rosso, S., Østerlind, A., Mack, T. M., Kirkpatrick, C., Holly, E. A., Green, A. C., et al. (2006) · Cancer Causes & Control · doi:10.1007/s10552-005-0281-y · Cited by 83
Evaluating invasive cutaneous melanoma: Is the initial biopsy representative of the final depth?
Ng, P., BARZILAI, D. A., Ismail, S. A., et al. (2003) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2003.106 · Cited by 83
Excision Margins for Primary Cutaneous Melanoma
Lens, M. B. (2007) · Archives of Surgery · doi:10.1001/archsurg.142.9.885 · Cited by 81
Evaluation of staging chest radiographs and serum lactate dehydrogenase for localized melanoma
Wang, T. S., Johnson, T. M., Cascade, P. N., Redman, B. G., Sondak, V. K., & Schwartz, J. L. (2004) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2004.02.017 · Cited by 72
Self-citationLymphatic Invasion Is Independently Prognostic of Metastasis in Primary Cutaneous Melanoma
Xu, X., Chen, L., Guerry, D., Dawson, P., Hwang, W., VanBelle, P., Elder, D. E., Zhang, P. J., Ming, M. E., Schuchter, L. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0490 · Cited by 69
Ebell, M. H., Siwek, J., Weiss, B. D., Woolf, S. H., Susman, J. L., Ewigman, B., & Bowman, M. A. (2004) · PubMed · Cited by 68
Tang, J. Y., Spaunhurst, K. M., Chlebowski, R. T., Wactawski‐Wende, J., Keiser, E., Thomas, F., Anderson, M. L., Zeitouni, N. C., Larson, J. C., & Stefanick, M. L. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr333 · Cited by 68
Review and Cross-Validation of Gene Expression Signatures and Melanoma Prognosis
Schramm, S., Campain, A. E., Yang, J. Y. H., & Mann, G. J. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.305 · Cited by 60
Prognostic Models for Melanoma
Halpern, A. C., & Schuchter, L. M. (2010) · American Registry of PathologyWashington, DC eBooks · doi:10.55418/9781933477107-ch12 · Cited by 57
Self-citationVariability in melanoma post-treatment surveillance practices by country and physician specialty
Cromwell, K. D., Ross, M. I., Xing, Y., Gershenwald, J. E., Royal, R. E., Lucci, A., Lee, J. E., & Cormier, J. N. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e328357d796 · Cited by 54
A Single-Institution Validation of the AJCC Staging System for Stage IV Melanoma
Neuman, H. B., Patel, A. B., Ishill, N. M., Hanlon, C., Brady, M. S., Halpern, A. C., Houghton, A. N., & Coit, D. G. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-9915-0 · Cited by 47
Self-citationNewton‐Bishop, J., Nolan, C., Turner, F., McCabe, M., Barrett, J. H., Boxer, C., Thomas, J., Coombes, G., & A’Hern, R. (2004) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1087-0024.2003.09118.x · Cited by 47
The incidence of second primary invasive melanoma in Queensland, 1982–2003
McCaul, K. A., Fritschi, L., Baade, P. D., & Coory, M. D. (2007) · Cancer Causes & Control · doi:10.1007/s10552-007-9106-5 · Cited by 45
Management of Periocular Cutaneous Melanoma with a Staged Excision Technique and Permanent Sections
Demirci, H., Johnson, T. M., Frueh, B. R., et al. (2008) · Ophthalmology · doi:10.1016/j.ophtha.2008.06.011 · Cited by 43
Self-citationCartee, T. V., Kini, S. P., & Chen, S. C. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2011.05.032 · Cited by 42
Armour, K., Mann, S., & Lee, S. B. (2005) · Australasian Journal of Dermatology · doi:10.1111/j.1440-0960.2005.00144.x · Cited by 41
Follow‐Up Recommendations for Patients with Stage I Malignant Melanoma
ROMERO, J. B., Stefanato, C. M., Kopf, A. W., & Bart, R. S. (1994) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1994.tb00462.x · Cited by 40
McKenna, D. B., Lee, R. J., Prescott, R. J., & Doherty, V. R. (2004) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2004.05849.x · Cited by 33
Variation in the Depth of Excision of Melanoma: A Survey of US Physicians
DeFazio, J., Marghoob, A. A., Pan, Y., Dusza, S. W., Khokhar, A., & Halpern, A. C. (2010) · Archives of Dermatology · doi:10.1001/archdermatol.2010.156 · Cited by 27
Self-citation
Cited by
Guidelines of care for the management of primary cutaneous melanoma
Swetter, S. M., Tsao, H., Bichakjian, C. K., Curiel-Lewandrowski, C., Elder, D. E., Gershenwald, J. E., Guild, V., Grant-Kels, J. M., Halpern, A. C., Johnson, T. M., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.08.055 · Cited by 727
Self-citationConnolly, S. M., Baker, D. R., Coldiron, B. M., Fazio, M. J., Storrs, P. A., Vidimos, A. T., Zalla, M. J., Brewer, J. D., Smith Begolka, W., Berger, T. G., et al. (2012) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2012.06.009 · Cited by 543
Self-citationKassem, M. A., Hosny, K. M., & Fouad, M. M. (2020) · IEEE Access · doi:10.1109/access.2020.3003890 · Cited by 407
Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma
Maibach, F., Sadozai, H., Seyed Jafari, S. M., Hunger, R. E., & Schenk, M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02105 · Cited by 312
Teledermatology: idea, benefits and risks of modern age - a systematic review based on melanoma
Pala, P., Bergler-Czop, B. S., & Gwiżdż, J. (2020) · Advances in Dermatology and Allergology · doi:10.5114/ada.2020.94834 · Cited by 83
Metadata
- Authors
- Bichakjian, C. K., Halpern, A. C., Johnson, T. M., Foote Hood, A., Grichnik, J. M., Swetter, S. M., Tsao, H., Barbosa, V. H., Chuang, T.-Y., Duvic, M., Ho, V. C., Sober, A. J., Beutner, K. R., Bhushan, R., & Smith Begolka, W.
- Venue
- Journal of the American Academy of Dermatology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 65
- Issue
- 5
- Pages
- 1032-1047
- ISSN
- 0190-9622 (ISSN-L)
- OpenAlex
- W2106005668
- Cited by
- 616
- References
- 105
- FWCI
- 13.65
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.